There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K47/6889
Pages in category "CPC A61K47/6889"
The following 41 pages are in this category, out of 41 total.
2
- 20250161478. Linker Payloads Conjugat (GLYKOS FINLAND OY)
- 20250161479. Transglutaminase Conjug (Paul Scherrer Institut)
- 20250170267. Antibody-drug Conjugate Precur (UBE)
- 20250170268. Methods Tools Conjug (Merck Patent)
- 20250177553. Novel Antibody Drug Conjugate (ABTIS ., .)
- 20250177554. Modified Antibody, Antibody-conj (SynAffix B.V.)
- 20250186606. Modular Linker (Heidelberg Pharma Research)
- 20250195682. Improved Cell-target (Sapreme Technologies B.V.)
- 20250195683. Antibody-drug Conjugate, Pharmaceutical Composition Thereof Use Th (SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL ., .)
- 20250205356. (PRIMELINK BIOTHERAPEUTICS (SHENZHEN) .,)
- 20250213716. Protease-cleavable S (CytomX Therapeutics, .)
- 20250228961. Practical (Wisconsin Alumni Research Foundation)
A
C
D
G
H
N
R
S
T
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- The Board of Regents of the University of Texas System Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024